Literature DB >> 19521982

Caveolin-1 tumor-promoting role in human melanoma.

Federica Felicetti1, Isabella Parolini, Lisabianca Bottero, Katia Fecchi, Maria Cristina Errico, Carla Raggi, Mauro Biffoni, Francesca Spadaro, Michael P Lisanti, Massimo Sargiacomo, Alessandra Carè.   

Abstract

Caveolin-1 (Cav-1), a member of the caveolin family, regulates caveolae-associated signaling proteins, which are involved in many biological processes, including cancer development. Cav-1 was found to exert a complex and ambiguous role as oncogene or tumor suppressor depending on the cellular microenvironment. Here we investigated Cav-1 expression and function in a panel of melanomas, finding its expression in all the cell lines. The exception was the primary vertical melanoma cell line, WM983A, characterized by the lack of Cav-1, and then utilized as a recipient for Cav-1 gene transduction to address a series of functional studies. The alleged yet controversial role of phospho (Ph)-Cav-1 on cell regulation was also tested by transducing the nonphosphorylatable Cav-1Y14A mutant. Wild-type Cav-1, but not mutated Cav-1Y14A, increased tumorigenicity as indicated by enhanced proliferation, migration, invasion and capacity of forming foci in semisolid medium. Accordingly, Cav-1 silencing inhibited melanoma cell growth reducing some of the typical traits of malignancy. Finally, we detected a secreted fraction of Cav-1 associated with cell released microvesicular particles able to stimulate in vitro anchorage independence, migration and invasion in a paracrine/autocrine fashion and, more important, competent to convey metastatic asset from the donor melanoma to the less aggressive recipient cell line. A direct correlation between Cav-1 levels, the amount of microvesicles released in the culture medium and MMP-9 expression was also observed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521982      PMCID: PMC2805039          DOI: 10.1002/ijc.24451

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

1.  Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth.

Authors:  J A Engelman; C C Wykoff; S Yasuhara; K S Song; T Okamoto; M P Lisanti
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

2.  Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma.

Authors:  A Baldi; D Santini; T Battista; E Dragonetti; G Ferranti; T Petitti; A M Groeger; A Angelini; R Rossiello; F Baldi; P G Natali; M G Paggi
Journal:  J Cell Biochem       Date:  2001 Aug 21-Sep 5       Impact factor: 4.429

3.  Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit.

Authors:  Jun Niu; Douglas J Dorahy; Xinhua Gu; R J Scott; Brian Draganic; Nuzhat Ahmed; Michael V Agrez
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

4.  HOXB7 constitutively activates basic fibroblast growth factor in melanomas.

Authors:  A Caré; A Silvani; E Meccia; G Mattia; A Stoppacciaro; G Parmiani; C Peschle; M P Colombo
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.

Authors:  Giusy Fiucci; Dana Ravid; Reuven Reich; Mordechai Liscovitch
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

6.  Role of PLZF in melanoma progression.

Authors:  Federica Felicetti; Lisabianca Bottero; Nadia Felli; Gianfranco Mattia; Catherine Labbaye; Ester Alvino; Cesare Peschle; Mario P Colombo; Alessandra Carè
Journal:  Oncogene       Date:  2004-06-03       Impact factor: 9.867

Review 7.  Transcriptional regulation of metastasis-related genes in human melanoma.

Authors:  Okot Nyormoi; Menashe Bar-Eli
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Caveolin-1 and MAL are located on prostasomes secreted by the prostate cancer PC-3 cell line.

Authors:  Alicia Llorente; María C de Marco; Miguel A Alonso
Journal:  J Cell Sci       Date:  2004-10-05       Impact factor: 5.285

9.  Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

Authors:  Giovanna Andreola; Licia Rivoltini; Chiara Castelli; Veronica Huber; Paola Perego; Paola Deho; Paola Squarcina; Paola Accornero; Francesco Lozupone; Luana Lugini; Annarita Stringaro; Agnese Molinari; Giuseppe Arancia; Massimo Gentile; Giorgio Parmiani; Stefano Fais
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

10.  B lymphocytes secrete antigen-presenting vesicles.

Authors:  G Raposo; H W Nijman; W Stoorvogel; R Liejendekker; C V Harding; C J Melief; H J Geuze
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  49 in total

1.  Cross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression.

Authors:  Ioana L Popa; Adina L Milac; Livia E Sima; Petruta R Alexandru; Florin Pastrama; Cristian V A Munteanu; Gabriela Negroiu
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

Review 2.  The biological significance and clinical applications of exosomes in ovarian cancer.

Authors:  Kalpana Deepa Priya Dorayappan; John J Wallbillich; David E Cohn; Karuppaiyah Selvendiran
Journal:  Gynecol Oncol       Date:  2016-04-10       Impact factor: 5.482

3.  PPARα and PPARγ protect against HIV-1-induced MMP-9 overexpression via caveolae-associated ERK and Akt signaling.

Authors:  Wen Huang; Ibolya E András; Geun Bae Rha; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2011-08-12       Impact factor: 5.191

4.  Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells.

Authors:  Aniruddha Sengupta; Silvia Mateo-Lozano; Oscar M Tirado; Vicente Notario
Journal:  Int J Oncol       Date:  2011-03-03       Impact factor: 5.650

Review 5.  Caveolin-1 in oral squamous cell carcinoma microenvironment: an overview.

Authors:  Samapika Routray
Journal:  Tumour Biol       Date:  2014-08-16

Review 6.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

7.  Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: role of adipokines.

Authors:  Parmanand Malvi; Balkrishna Chaube; Vimal Pandey; Maleppillil Vavachan Vijayakumar; Purushotham Reddy Boreddy; Naoshad Mohammad; Shivendra Vikram Singh; Manoj Kumar Bhat
Journal:  Mol Oncol       Date:  2014-11-26       Impact factor: 6.603

8.  Discovering modulators of gene expression.

Authors:  Ozgün Babur; Emek Demir; Mithat Gönen; Chris Sander; Ugur Dogrusoz
Journal:  Nucleic Acids Res       Date:  2010-05-13       Impact factor: 16.971

9.  E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells.

Authors:  Lorena Lobos-González; Lorena Aguilar; Jorge Diaz; Natalia Diaz; Hery Urra; Vicente A Torres; Veronica Silva; Christopher Fitzpatrick; Alvaro Lladser; Keith S Hoek; Lisette Leyton; Andrew F G Quest
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-11       Impact factor: 4.693

Review 10.  Caveolae as plasma membrane sensors, protectors and organizers.

Authors:  Robert G Parton; Miguel A del Pozo
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.